Abstract
Neuromelanin (NM) is a dark polymer pigment produced in certain populations of catecholaminergic neurons in the brain. It is present in various areas of the human brain, most often in the substantia nigra (SN) pars compacta and the locus coeruleus, the main centers of dopaminergic and noradrenergic innervation, respectively. Interest in NM has revived in recent years due to the alleged link between NM and the particular vulnerability of NM-containing neurons to neurodegeneration. The aim of this work was to study the structural, cytochemical, and localization features of cytoplasmic and extracellular NM (eNM) in the human SN pars compacta during normal aging. Sections of human SN from young/middle-aged adults (25 to 51 years old, n=7) and older adults (60 to 78 years old, n=5), all of which had no neurological disorders, were stained histochemically for metals (Perls’ reaction, Mayer's hematoxylin) and immunohistochemically for tyrosine hydroxylase (TH), Iba- 1, and CD68. It was shown that dopaminergic neurons in SN pars compacta differ in the amount of NM and the intensity of TH-immunoreactivity. The number of NM-containing neurons with decreased TH-immunoreactivity positively correlates with age. eNM is present in SN pars compacta in both young/middle-aged and older adults. The number of eNM accumulations increases with aging. Cytoplasmic and eNM are predominantly not stained using histochemical methods for detecting metals in people of all ages. We did not detect the appearance of amoeboid microglia in human SN pars compacta with aging, but we found an age-related increase in microglial phagocytic activity. The absence of pronounced microgliosis, as well as a pronounced loss of NM-containing neurons, indicate the absence of neuroinflammation in human SN pars compacta during normal aging.
Key words: neuromelanin, substantia nigra, human, aging, microglia, Iba-1, Perls’ reaction
Introduction
Melanins are the natural dark pigments that include different types of melanin found in bacteria, fungi, invertebrate and vertebrate animals. In mammals, three types of melanin are known; these are eumelanin, pheomelanin and neuromelanin (NM). Pheomelanin and eumelanin are peripheral pigments implicated in coloration of hair, skin and iris. NM is found in the central nervous system, primarily in primates including humans. It is located in various brain areas, most abundantly in the substantia nigra (SN) pars compacta and locus coeruleus, the major brain centers of dopaminergic and noradrenergic innervation, respectively.1 In normal adult human SN pars compacta, NM is densely packed in the cytoplasm of most neurons.
The structure and synthesis of NM remains partly understood. The problem is, at a great extent, because the pigment is an amorphous insoluble complex substance with inconsistent composition. Since NM is most often seen in catecholaminergic (dopamine- or noradrenaline-containing) cells, it is logical to assume that catecholamines are involved in the synthesis of the pigment. This view is supported by the finding that tyrosine (amino acid, the precursor of both dopamine and norepinephrine) and enzyme tyrosinase are involved in the synthesis of peripheral melanins, the eumelanin and pheomelanin.2 However, tyrosinase has not been found in the human brain (particularly, the substantia nigra) or found in negligible amounts.3,4 Therefore, NM synthesis via spontaneous nonenzymatic dopamine auto-oxidation has been supposed,5 although involvement of tyrosinase or any other enzyme in production of NM cannot be excluded.6 Derivatives of catecholamines copolymerize with cysteine, some proteins, lipids and aliphatic compounds producing a complex macromolecule with varying set of components.7-10 Moreover, NM can absorb metals, such as iron, copper, manganese, lead and mercury, some drugs and chemicals including toxic compounds.11-18 These data suggest that NM may serve a neuroprotective function as a chelator for toxic metals and chemicals.
The other side of the coin is that accumulation of potentially toxic compounds in NM granules is a risk factor. Indeed, if NMcontaining neurons degenerate (whatever the cause), the NM granules leaks into the intercellular space, and dangerous metals and substances can injure other nerve cells. Particularly, iron released from NM can contribute to formation of cytotoxic free radicals originating from elevated levels of H2O2 via Fenton reaction.19 Furthermore, eNM can activate the CNS resident immune cells, microglia and, in this way, induces neuroinflammation that can result in neurodegeneration.20-25 Considering this properties of NM, its direct or indirect implication in degeneration of dopaminergic neurons in the SN and, consequently, it is possible role in the etiology and pathogenesis of Parkinson’s disease has been suggested.23,25-30 The present study aims to analyze the structural, cytochemical and localization features of intra- and eNM in human SN pars compacta during normal aging.
Materials and Methods
Human brain specimens
Midbrain fragments of neurologically normal individuals (n=12, males and females, ages 25 to 78 years) were used in this work. Individuals were categorized by age into young/middle-aged adults (25-51 years, n=7) and older adults (60-78 years, n=5). Paraffin blocks of 1-1,5 cm3 (10x10x10-mm) were obtained from the archive of Department of General and Special Morphology, Institute of Experimental Medicine (St. Petersburg, Russia). Initially the autopsy tissue was fixed in the zinc-ethanol-formalin31 in a ratio of 1:50 (material:fixative). For morphological analysis, 5 μm thick sections were cut using rotary (RM 2125RT, Leica, Germany) or sliding (Leica SM 2000R, Leica, Germany) microtome and mounted on poly-L-lysine-coated (Polysine™, Menzel- Gläser, Germany) glass slides.
Histochemistry
Mallory’s staining with hematoxylin32 and Perls’ reaction33 were used to reveal metal compounds.
Immunohistochemistry
Before immunohistochemistry study the sections were deparaffinized and rehydrated routinely. For better antigen detection, the heat-induced antigen retrieval in modified citrate buffer, pH 6.1 (S1700, Agilent-Dako, Santa Clara, CA, USA) was performed in a conventional steamer for 25 min. Endogenous peroxidase was blocked in a 3% aqueous solution of hydrogen peroxide for 10 min. The preparations were pretreated with the blocking solution (Protein Block, Spring Bioscience, Pleasanton, CA, USA) for 10 min at room temperature. After that anti-tyrosine hydroxylase rabbit polyclonal (Abcam, Cambridge, UK; ab112; 1:1000), anti-Iba-1 protein (AIF1) goat polyclonal (1:200, ab5076, Abcam, UK), and anti-CD68 mouse monoclonal (clone PG-M1, ready-touse, N1576, Dako, Glostrup, Denmark) primary antibodies were applied. To visualize the applied primary antibodies the following reagents were used: for rabbit antibodies, Reveal Polyvalent HRP DAB (Spring Bioscience); for goat antibodies, biotinylated antigoat antibody (Agilent-Dako) and streptavidin conjugated with HRP (streptavidin/horse radish peroxidase; Spring Bioscience); for mouse antibodies, MACH 2 Mouse HRP-Polymer (BioCare Medical, Pacheco, CA, USA). The peroxidase label was detected using diaminobenzidine chromogen (DAB+; Agilent-Dako). After immunocytochemical reactions, some sections were post-stained with hematoxylin. For all immunohistochemical reactions, the control reactions recommended by the antibody manufacturer were performed.
Microscopy
The sections were examined in transmitted light under a Leica DM750 (Leica, Wetzlar, Germany) microscope and photographed using ICC50 camera (Leica). Images were processed using ImageJ (NIH, USA) software. Neurons and extracellular melanin were counted in 12 fields of view with an area of 0.08 mm2.
To detect autofluorescence of NM and lipofuscin in brain tissue, unstained sections enclosed in a permanent medium were used. The sections were examined under LSM710 confocal laser microscope (Carl Zeiss, Jena, Germany) using lasers with wavelengths of 405 nm and 561 nm and Zen-2012 (Carl Zeiss) software.
Statistical analysis
Statistical analysis was conducted using RStudio v1.2 software (http://www.rstudio.com/). Age groups and morphometric data were analyzed. Continuous variables are presented as means and standard deviations (SD). Differences between age groups were assessed using the unpaired Mann-Whitney test. Correlation between morphometric data and age was analyzed with the Spearman rank correlation test. The p<0.05 was considered statistically significant.
Results
Tyrosine hydroxylase and NM distribution in neurons of the human SN pars compacta
The light microscopic analysis revealed that the SN pars compacta contains densely-packed tyrosine hydroxylase (TH)- immunoreactive (IR) dopaminergic neurons (Figures 1A and 2 D,E). TH-immunostaining was localized to perikaryon and processes of the neurons. Cytoplasm of dopaminergic neurons was filled with NM granules. The neurons of SN pars compacta differed according to their amount of cytoplasmic NM and THimmunoreactivity. Most neurons have numerous densely packed NM granules in perikaryon. TH-immunoreactivity of these neurons was either intensive (Figure 1A arrow 1), or medium/weak (Figure 1A, arrow 2). Quantitative analysis showed that the proportion of neurons with reduced TH-immunoreactivity increases with age (Figure 2A). In young/middle-aged adults, the percentage of such neurons averages 15.6% (SD 10.6), while in older adults it is 40.2% (SD 19.5), which do not reach statistical significance (W=29, p=0.07). Correlation analysis revealed a positive relationship between age and the number of NM-containing neurons with decreased TH-immunoreactivity (r = 0.6, p=0.04).
In addition to NM-containing TH-IR neurons, SN pars compacta contains NM-filled TH-immunonegative neurons (Figure 1A, arrow 3). Their number in young/middle-aged people ranges from 3% to 29% (mean 5.6, SD 10.5), in old people – from 3% to 16% (mean 7, SD 6.4), which is statistically insignificant difference (W=11.5, p=0.36) (Figure 2B). Finally, few TH-immunonegative neurons that do not contain NM were found in the SN pars compacta (Figure 1A, arrow 4). They were rare in all studied samples and had no signs of degeneration.
eNM in the human SN pars compacta
In 10 out of 12 analyzed cases, accumulations of eNM were detected in human SN pars compacta (Figures 1A and 2F, arrowhead). Quantification has shown that eNM accumulations are rare in young/middle-aged people. Their average quantity is 6 per mm2 tissue (SD 6). On the contrary, in old people, accumulations of eNM are often detected. Their average number is 29 per mm2 tissue (SD 35), which was statistically insignificant in comparison to people of young/middle age (W=28, p=0.1) (Figure 2C). However, correlation analysis showed a positive relationship between the age and the number of eNM accumulations (r=0.63, p=0.03).
Staining with Mallory’s hematoxylin
In sections stained with Mallory’s hematoxylin, eNM was never bound the stain, retaining its golden-brown color (Figure 1 B,C, NM). We also did not find the appearance of intracellular NM staining with age. We observed medium-sized fine-grained clusters stained in a dark color in the SN pars compacta parenchyma (Figure 1B, double arrow), but it is not possible to determine whether they are eNM aggregations or cytoplasmic inclusions of some cells. In one of the investigated cases (woman, 74-year-old), degenerating neurons with destructive NM stained darkly were identified (Figure 1B, eNM). In the area of the destructive NM, a dark-colored cell was present, which is probably a macrophage phagocytizing eNM. We also noted intense dark staining of the cytoplasm of perivascular macrophages in the SN pars compacta of most of the samples studied (Figure 1B, arrow).
Interestingly, in 2 cases excluded from the initial samples due to prolonged illness of subjects (man, 27 years old, pneumonia; woman, 87 years old, oncology), we found intense blue staining of the nucleus and intranuclear structures in some of the dopaminergic neurons in SN pars compacta (Figure 1C). The nucleolus was stained especially intensely in these neurons, with the formation of an unstained region of the giant fibrillar center (Figure 1C, line). In some neurons, numerous stained microstructures were also present in the nucleoplasm.
Pearls’ reaction for iron
NM accumulates iron and, thus, inactivates this redox-active metal.11 Therefore, we carried out the Pearls’ reaction for ferric iron. Pearls’ reaction for ferric iron failed to reveal staining of both intracellular NM (Figure 1 D,E, NM) and eNM (Figure 1D, arrowhead). All NM remained golden brown in both young/middle aged and older subjects. Cytoplasm of some perivascular macrophages was stained dark blue (Figure 1E, dark blue stain). This is probably due to the accumulation of the hemosiderin pigment, which contains iron oxide, in the cytoplasm of macrophages. As with the use of Mallory’s hematoxylin, we found blue staining of the nucleolus of some SN pars compacta neurons in 2 cases (Figure 1D, line) excluded from the initial samples due to prolonged illness of subjects.
Separate imaging of NM and lipofuscin pigments
Interestingly, in some cases, small cells were found in the parenchyma, the cytoplasm of which was filled with golden brown granules similar to NM (Figure 1D, arrow). These are probably macrophages that phagocytosed eNM or accumulated lipofuscin pigment in the cytoplasm, which is morphologically similar to NM. Lipofuscin can be distinguished from NM using fluorescence or confocal laser microscopy. A characteristic feature of lipofuscin is autofluorescence. We suggest using 561 nm laser to excite lipofuscin autofluorescence (Figure 3, L). The maximum emission is between 580 and 680 nm. Using a 405 nm laser to excite autofluorescence in neural tissue can enhance contrast. Unlike lipofuscin, NM is not autofluorescent (Figure 3, NM).
The state of microglia in the human SN during normal aging
Next, we studied the response of microglia to the presence of eNM in SN pars compacta (Figure 4). Using Iba-1 immunostaining, we did not detect the activation of microglia in SN pars compacta with age. In both young/middle-aged people and older adults, Iba-1-immunopositive microglia were evenly distributed over the entire SN pars compacta area and did not form clusters in any of the studied samples. Microglia had a ramified phenotype in both young/middle-aged and older adults (Figure 4A). The processes of microglia often approached the bodies of NM-containing neurons, contacting and surrounding them (Figure 4B). There were rare microgliocytes with an enlarged body and/or less branched processes in all cases. We did not find amoeboid microglia in SN pars compacta. In both age groups, the presence of Iba-1-immunoreactive perivascular macrophages localized near blood vessels was noted (Figure 4C). We did not observe the presence of activated microglia around clumps of eNM. Iba-1- immunoreactive microglia near such clusters always had a normal ramified morphology (Figure 4D).
Interestingly, age-dependent differences in CD68 staining in human SN pars compacta were found (Fig. 4E-F). There were only CD68-immunopositive perivascular macrophages in the SN pars compacta of young/middle-aged people (Figure 4E, black arrowhead) and no CD68-immunostaining in the brain parenchyma (Figure 4E). In contrast, SN pars compacta of older adults contained a large amount of discrete CD68-immunopositive granules (Figure 4F, red arrowhead). Sometimes CD68-immunopositive aggregates formed profiles of ramified cells (Figure 4F, red arrow). Similar to Iba-1 staining, we did not detect microglia with amoeboid morphology when immunostained for CD68.
Discussion
NM is a byproduct of the metabolism of dopamine or norepinephrine and is formed during the synthesis of these neurotransmitters in catecholaminergic neurons. In this context, our detection of NM-free neurons in human SN pars compacta may result from the presence of nondopaminergic neurons in this region. For example, these can be cholinergic neurons.34
In humans, NM is first detected in early childhood and gradually accumulates with age until it occupies most of the cytoplasm of neurons, since neurons do not appear to have mechanisms to destroy or remove this pigment.6,35 NM synthesis is believed to be neuroprotective, as it removes excess cytosolic catechins and their derivatives, and chelates toxic metals.36,37 The recent development of a murine model producing human NM allowed for the first time the experimental evaluation of the effects of age-related accumulation of NM to levels achieved in the elderly in vivo. The use of this model has shown that the progressive intracellular accumulation of NM that occurs with age ultimately induces PD-like neuronal dysfunction and neurodegeneration once a certain threshold of NM accumulation is reached. Therefore, while NM synthesis itself may be neuroprotective, its long-term accumulation has detrimental effects.6 This is in good agreement with our data on a decrease in the TH-immunoreactivity of dopaminergic neurons in SN pars compacta with age. Probably, the found presence of neurons with different degrees of TH-immunoreactivity reflects the difference in the functional state of dopaminergic neurons in human SN pars compacta. The results obtained indicate a gradual decrease in the functional activity of dopaminergic neurons with aging.
After the death of NM-containing neurons, NM is released into the extracellular space. Large amounts of eNM are observed in the brains of older adults when compared to the brains of younger adults.20 In agreement with these data, we found a positive correlation between age and the amount of eNM in the human SN pars compacta. Increased amount of eNM is thought to stimulate dysfunction and degeneration of the remaining NM-containing neurons. 38 In our study, we noted an age-dependent decrease in THimmunoreactivity of dopaminergic neurons, which may indicate the development of dysfunction. But we did not find a pronounced loss of NM-containing neurons in SN pars compacta with aging.
One of the difficulties in studying eNM by light microscopy is its morphological similarity with intracellular accumulations of lipofuscin. Lipofuscin is a protein- and lipid-based pigment whose accumulation in neurons is associated with post-mitotic cellular aging. Its amount increases with age. Lipofuscin granules accumulate mainly in the perinuclear region, but can be present throughout the perikaryon, in dendrites, axons, and even in presynapses.39 Lipofuscin is also produced by glial cells, but since these cells, unlike neurons, continue to divide, the amount of lipofuscin is diluted via division. The high concentration of lipofuscin in glial cells is the result of their uptake of neuronal lipofuscin.39,40 In present study, we propose the use of confocal microscopy to distinguish between NM and lipofuscin in human SN pars compacta. Unlike lipofuscin, NM is not autofluorescent when excited with a 561 nm laser. This approach can be applied to more accurately identify the two pigments.
According to modern concepts, NM is an insoluble and degradation resistant complex polymeric compound. It consists of a mixture of derivatives of oxidized catecholamines, lipids, peptides and metals that accumulate in autophagosomes and/or lysosomes of catecholaminergic neurons. Based on data on the accumulation of metals in NM,37 we estimated the presence of metals in human SN pars compacta using staining with Mallory’s hematoxylin. The essence of the technique is that a hematoxylin solution is prepared without the addition of metal salts. When sections are treated with such hematoxylin, it reacts with structures containing copper and/or iron, staining them blue or black.32 Unfortunately, we did not detect dark staining of intracellular and/or eNM when using Mallory’s hematoxylin, which may be due to insufficient sensitivity of the method.
Iron is a most typical metal for NM, which accumulates in large quantities. Iron and other redox-active metals are inactivated by interaction with NM, and it has been suggested that the chelating potential of NM allows the cell to inactivate potentially toxic metal ions.11 We did not detect NM staining using the Perls’ reaction. Similar results were obtained earlier in the study of SN pars compacta of patients with Parkinson’s disease.41 Classical Perls’ staining in this case showed that in Parkinson’s disease patients, Fe3+ accumulates mainly in macrophages. Its presence has also been noted in astrocytes, reactive microglia, unpigmented neurons, and damaged areas devoid of pigmented neurons. NM in neuronal cytoplasm and eNM were not stained by Perls’ reaction.41 However, other methods have repeatedly shown the presence of large amounts of iron in NM-containing SN neurons in norm and Parkinson’s disease. Thus, Zecca et al. showed that NM is the main storage of iron in SN neurons in normal humans, and its content increases 100-fold during aging.37,42 Several precise methods with a subcellular resolution such as laser microprobe mass analysis and energy dispersive X-ray microanalysis have demonstrated an accumulation of iron in NM granules in the SN pars compacta of PD patients.43,44 Application of Mössbauer spectroscopy showed that SN contains high-spin ferric iron, which is in a ferritin-like ironoxyhydroxide cluster form.42 Negative results of NM staining with Perls’ reaction may be associated with insufficient sensitivity of the method. Probably, the iron content in NM is insufficient for detection by histochemical method. Iron can be detected using the classical Perls’ method only at a significant concentration, as in the case of hemosiderin in macrophages.
When using either of both, Mallory’s hematoxylin and Perls’ reaction, we found blue staining of the nucleolus of some SN pars compacta neurons in 2 cases excluded from the initial samples due to prolonged illness of subjects. This indicates the pathologic accumulation of non-heme iron in the nucleoli of dopaminergic neurons of human SN pars compacta. The presence of iron in the nucleoli of NM-containing neurons of human SN pars compacta was described in this Laboratory earlier.45,46 Similar data were recently obtained for nerve cells in the rat brain. Using a nuclear microprobe and scanning proton induced X-ray emission spectrometry Reinert et al. conducted a quantitative analysis of the concentration of iron in neurons and glial cells of different brain areas in rats, and showed that the nucleolus has a higher concentration of iron than the nucleus and cytoplasm of neurons.47 It is known that the nucleolus is the site of synthesis of ribosomal RNA (rRNA) and the site of assembly of ribosomal subunits. Iron can also be a cofactor in some nucleolar proteins. Roschzttardtz et al. suggested that iron may be involved in rRNA metabolism.48 Moreover, ferritin binds to DNA49 and can concentrate iron in the nucleolus. Another source may be iron, which is directly bound to RNA. The ironbinding capacity of rRNA is higher than that of mRNA or tRNA,50 which leads to higher iron concentrations in the nucleolus. For Alzheimer’s disease, it has been shown that rRNA is oxidized under the influence of bound iron,50 that is, the nucleolus may be especially vulnerable to oxidative activity.
According to the literature, the extraneuronal NM is associated with microglial activation.14,22 The contribution of eNM to the development of neuroinflammation and death of dopaminergic neurons in SN is widely discussed in the context of PD. eNM is insoluble, contains a large amount of reactive iron, and in PD it can exist in the extracellular spaces in large quantities and for a long time.37,51 Therefore, NM released from dying neurons is a strong candidate for an agent that induces chronic inflammation in SN. By itself, eNM is not toxic to neurons. However, in vitro and in vivo studies have shown the ability of eNM to activate microglia.22,23,25 Thus, the addition of human NM to microglia cultures was noted to activate positive chemotaxis, the production of superoxide, nitric oxide, hydrogen peroxide, as well as the release of tumor necrosis factor-α, interleukin-6 and NO. The release of inflammatory molecules and cytotoxic agents by NM-activated microglia promotes damage and degeneration of dopaminergic neurons. In vivo NM injected into rat SN induces microgliosis and death of dopaminergic neurons.22,23 Given that there is a continuous release of NM by dying neurons in SN in PD, it has been suggested that eNM can cause sustained activation of microglia and, as a consequence, neurodegeneration in PD.24
The question remains open whether similar processes develop in human SN during normal aging. Since the amount of eNM in the SN increases with aging, it seems logical to expect a significant activation of microglia in the SN in the elderly. Previously, Beach et al. reported a pronounced microglial response in SN of elderly people without neurological disease.20 They described the presence of hypertrophied MHC Class II – immunoreactive cells in the SN of the elderly. These cells were especially numerous around the extracellular deposits of NM. Sometimes the processes of microglia, as well as rounded amoeboid cells, contained phagocytosed NM.20
In our study, we found no morphological signs of microglia activation against the background of an increase in the amount of eNM in SN in older adults. Similar to our findings, another study also stated no significant correlation between normal aging and microglial activation in human SN pars compacta.52 Jyothi et al. found that the number of microglia does not significantly increase with age in any of the human SN pars compacta regions. Morphologically activated microglia are rare.52A study in primates also did not show a significant correlation between normal aging and the amount of microglia in the SN pars compacta.53 Probably, eNM is not the main factor in the activation of microglia, and in the case of PD, the pronounced microglial response is not directly associated with an increase in the amount of eNM.
Importantly, we observed an increase in CD68 immunoreactivity with age in human SN pars compacta. CD68 is a lysosomal marker of phagocytic activity, mainly localized in microglia and perivascular macrophages. Although there is some CD68 expression on resting microglia, it is commonly considered a marker of activated phagocytic microglia.54,55 However, we did not detect CD68-immunopositive microglia with amoeboid morphology in aged human SN pars compacta, suggesting that ramified microglia can perform active phagocytosis. The absence of pronounced microgliosis, as well as a pronounced loss of NM-containing neurons, may indicate the absence of neuroinflammation in human SN pars compacta during normal aging.
In conclusion, this study examined the structural, cytochemical and localization features of NM in human SN pars compacta. It was shown that dopaminergic neurons differ in the amount of cytoplasmic NM and the intensity of TH-immunoreactivity in an agedependent manner. Intra- and extracellular NM predominantly does not stain when using histochemical methods for detecting metals (Perl’s method, Mallory’s hematoxylin). The amount of extracellular NM in human SN pars compacta is positively correlated with age. No signs of neuroinflammation were found in human SN pars compacta during normal aging. We have demonstrated vast distribution of ramified microglia in SN of both, young/middle aged and older adults. An increase in the phagocytic activity of ramified microglia was observed with aging.
Funding Statement
Funding: This work was supported by the funds of the Institute of Experimental Medicine, St. Petersburg, Russian Federation.
References
- 1.Usunoff KG, Itzev DE, Ovtscharoff WA, Marani E.Neuromelanin in the human brain: A review and atlas of pigmented cells in the substantia nigra. Arch Physiol Biochem 2002;110:257-369. [DOI] [PubMed] [Google Scholar]
- 2.Simon JD, Peles D, Wakamatsu K, Ito S.Current challenges in understanding melanogenesis: bridging chemistry, biological control, morphology, and function. Pigment Cell Melanoma Res 2009;22:563-79. [DOI] [PubMed] [Google Scholar]
- 3.Greggio E, Bergantino E, Carter D, Ahmad R, Costin GE, Hearing VJ, et al. Tyrosinase exacerbates dopamine toxicity but is not genetically associated with Parkinson's disease. J Neurochem 2005;93:246-56. [DOI] [PubMed] [Google Scholar]
- 4.Tribl F, Arzberger T, Riederer P, Gerlach M.Tyrosinase is not detected in human catecholaminergic neurons by immunohistochemistry and Western blot analysis. Gerlach M, Deckert J, Double K, Koutsilieri E, editors. Neuropsychiatric disorders an integrative approach. Journal of Neural Transmission Supplementa. Vienna: Springer; 2007. p. 51-5. [DOI] [PubMed] [Google Scholar]
- 5.Monzani E, Nicolis S, Dell'Acqua S, Capucciati A, Bacchella C, Zucca FA, et al. Dopamine, oxidative stress and proteinquinone modifications in Parkinson's and other neurodegenerative diseases. Angew Chem Int Ed Engl 2019;58:6512-27. [DOI] [PubMed] [Google Scholar]
- 6.Vila M. Neuromelanin, aging, and neuronal vulnerability in Parkinson's disease. Mov Disord 2019;34:1440-51. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.d'Ischia M, Prota G.Biosynthesis, structure, and function of neuromelanin and its relation to Parkinson's disease: a critical update. Pigment Cell Res 1997;10:370-6. [DOI] [PubMed] [Google Scholar]
- 8.Zecca L, Costi P, Mecacci C, Ito S, Terreni M, Sonnino S.Interaction of human substantia nigra neuromelanin with lipids and peptides. J Neurochem 2000;74:1758-65. [DOI] [PubMed] [Google Scholar]
- 9.Wakamatsu K, Fujikawa K, Zucca FA, Zecca L, Ito S.The structure of neuromelanin as studied by chemical degradative methods. J Neurochem 2003;86:1015-23. [DOI] [PubMed] [Google Scholar]
- 10.Engelen M, Vanna R, Bellei C, Zucca FA, Wakamatsu K, Monzani E, et al. Neuromelanins of human brain have soluble and insoluble components with dolichols attached to the melanic structure. PLoS One 2012;7:e48490. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Double KL, Gerlach M, Schünemann V, Trautwein AX, Zecca L, Gallorini M, et al. Iron-binding characteristics of neuromelanin of the human substantia nigra. Biochem Pharmacol 2003;66:489-94. [DOI] [PubMed] [Google Scholar]
- 12.Gerlach M, Double KL, Ben-Shachar D, Zecca L, Youdim MB, Riederer P.Neuromelanin and its interaction with iron as a potential risk factor for dopaminergic neurodegeneration underlying Parkinson's disease. Neurotox Res 2003;5:35-44. [DOI] [PubMed] [Google Scholar]
- 13.Ostergren A, Annas A, Skog K, Lindquist NG, Brittebo EB. Long-term retention of neurotoxic beta-carbolines in brain neuromelanin. J Neural Transm (Vienna) 2004;111:141-57. [DOI] [PubMed] [Google Scholar]
- 14.Zecca L, Zucca FA, Wilms H, Sulzer D.Neuromelanin of the substantia nigra: a neuronal black hole with protective and toxic characteristics. Trends Neurosci 2003;26:578-80. [DOI] [PubMed] [Google Scholar]
- 15.Zecca L, Bellei C, Costi P, Albertini A, Monzani E, Casella L, et al. New melanic pigments in the human brain that accumulate in aging and block environmental toxic metals. Proc Natl Acad Sci USA 2008;105:17567-72. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Fasano M, Bergamasco B, Lopiano L.Is neuromelanin changed in Parkinson's disease? Investigations by magnetic spectroscopies. J Neural Transm (Vienna) 2006;113:769-74. [DOI] [PubMed] [Google Scholar]
- 17.Schroeder RL, Gerber JP. A reappraisal of Fe(III) adsorption by melanin. J Neural Transm (Vienna) 2014;121:1483-91. [DOI] [PubMed] [Google Scholar]
- 18.Karlsson O, Lindquist NG. Melanin and neuromelanin binding of drugs and chemicals: toxicological implications. Arch Toxicol 2016;90:1883-91. [DOI] [PubMed] [Google Scholar]
- 19.Knorle R. Neuromelanin in Parkinson’s Disease: from Fenton reaction to calcium signaling. Neurotox Res 2018;33:515-22. [DOI] [PubMed] [Google Scholar]
- 20.Beach TG, Sue LI, Walker DG, Lue LF, Connor DJ, Caviness JN, et al. Marked microglial reaction in normal aging human substantia nigra: correlation with extraneuronal neuromelanin pigment deposits. Acta Neuropathol 2007;114:419-24. [DOI] [PubMed] [Google Scholar]
- 21.Ishikawa A, Takahashi H.Clinical and neuropathological aspects of autosomal recessive juvenile parkinsonism. J Neurol 1998;245:P4-9. [DOI] [PubMed] [Google Scholar]
- 22.Wilms H, Rosenstiel P, Sievers J, Deuschl G, Zecca L, Lucius R.Activation of microglia by human neuromelanin is NFkappaB dependent and involves p38 mitogen-activated protein kinase: implications for Parkinson's disease. FASEB J 2003;17:500-2. [DOI] [PubMed] [Google Scholar]
- 23.Zecca L, Casella L, Albertini A, Bellei C, Zucca FA, Engelen M, et al. Neuromelanin can protect against iron-mediated oxidative damage in system modeling iron overload of brain aging and Parkinson's disease. J Neurochem 2008;106:1866-75. [DOI] [PubMed] [Google Scholar]
- 24.Zhang W, Phillips K, Wielgus AR, Liu J, Albertini A, Zucca FA, et al. Neuromelanin activates microglia and induces degeneration of dopaminergic neurons: implications for progression of Parkinson's disease. Neurotox Res 2011;19:63-72. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25.Zhang W, Zecca L, Wilson B, Ren HW, Wang YJ, Wang XM, et al. Human neuromelanin: an endogenous microglial activator for dopaminergic neuron death. Front Biosci (Elite Ed) 2013;5:1-11. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26.Carballo-Carbajal I, Laguna A, Romero-Giménez J, Cuadros T, Bové J, Martinez-Vicente M, et al. Brain tyrosinase overexpression implicates age-dependent neuromelanin production in Parkinson's disease pathogenesis. Nat Commun 2019;10:973. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27.Depboylu C, Schäfer MK, Arias-Carrion O, Oertel WH, Weihe E, Höglinger GU. Possible involvement of complement factor C1q in the clearance of extracellular neuromelanin from the substantia nigra in Parkinson disease. J Neuropathol Exp Neurol 2011;70:125-32. [DOI] [PubMed] [Google Scholar]
- 28.Lawana V, Um SY, Foguth RM, Cannon JR. Neuromelanin formation exacerbates HAA-induced mitochondrial toxicity and mitophagy impairments. Neurotoxicology 2020;81:147-60. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29.Prota G, d'Ischia M.Neuromelanin: a key to Parkinson's disease. Pigment Cell Res 1993;6:333-5. [DOI] [PubMed] [Google Scholar]
- 30.Xu S, Chan P.Interaction between neuromelanin and alpha-synuclein in Parkinson's disease. Biomolecules 2015;5:1122-42. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31.Korzhevskii DE, Sukhorukova EG, Kirik OV, Grigorev IP. Immunohistochemical demonstration of specific antigens in the human brain fixed in zinc-ethanol-formaldehyde. Eur J Histochem 2015;59:2530. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32.Mallory FB. Pathological technique: a practical manual for workers in pathological histology including directions for the performance of autopsies and for microphotography. Philadelphia and London: W.B. Saunders Co.; 1938. [Google Scholar]
- 33.Culling CFA, Allison RT, Barr WT. Cellular pathology technique. Oxford: Butterworth-Heinemann; 1985. [Google Scholar]
- 34.Korzhevskii DE, Grigor’ev IP, Sukhorukova EG, Guselnikova VV. Immunohistochemical characteristics of neurons in the substantia nigra of the human brain. Neurosci Behav Physi 2019;49:109-14. [Google Scholar]
- 35.Sulzer D, Mosharov E, Talloczy Z, Zucca FA, Simon JD, Zecca L.Neuronal pigmented autophagic vacuoles: lipofuscin, neuromelanin, and ceroid as macroautophagic responses during aging and disease. J Neurochem 2008;106:24-36. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 36.Sulzer D, Bogulavsky J, Larsen KE, Behr G, Karatekin E, Kleinman MH, et al. Neuromelanin biosynthesis is driven by excess cytosolic catecholamines not accumulated by synaptic vesicles. Proc Natl Acad Sci USA 2000;97:11869-74. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 37.Zecca L, Pietra R, Goj C, Mecacci C, Radice D, Sabbioni E.Iron and other metals in neuromelanin, substantia nigra, and putamen of human brain. J Neurochem 1994;62:1097-101. [DOI] [PubMed] [Google Scholar]
- 38.Moreno-García A, Kun A, Calero M, Calero O.the neuromelanin paradox and its dual role in oxidative stress and neurodegeneration. Antioxidants (Basel) 2021;10:124. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 39.Double KL, Dedov VN, Fedorow H, Kettle E, Halliday GM, Garner B, et al. The comparative biology of neuromelanin and lipofuscin in the human brain. Cell Mol Life Sci 2008;65:1669-82. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 40.Riga D, Riga S, Halalau F, Schneider F.Brain lipopigment accumulation in normal and pathological aging. Ann NY Acad Sci 2006;1067:158–63. [DOI] [PubMed] [Google Scholar]
- 41.Jellinger K, Paulus W, Grundke-Iqbal I, Riederer P, Youdim MB. Brain iron and ferritin in Parkinson’s and Alzheimer’s diseases. J Neural Transm Park Dis Dement Sect 1990;2:327–40. [DOI] [PubMed] [Google Scholar]
- 42.Zecca L, Gallorini M, Schünemann V, Trautwein AX, Gerlach M, Riederer P, et al. Iron, neuromelanin and ferritin content in the Substantia Nigra of normal subjects at different ages: consequences for iron storage and neurodegenerative processes. J Neurochem 2001;76:1766-73. [DOI] [PubMed] [Google Scholar]
- 43.Jellinger K, Kienzl E, Rumpelmair G, Riederer P, Stachelberger H, Ben-Shachar D, et al. Iron-melanin complex in substantia nigra of parkinsonian brains: an x-ray microanalysis. J Neurochem 1992;59:1168-71. [DOI] [PubMed] [Google Scholar]
- 44.Kienzl E, Jellinger K, Stachelberger H, Linert W.Iron as catalyst for oxidative stress in the pathogenesis of Parkinson's disease? Life Sci 1999;65:1973-6. [DOI] [PubMed] [Google Scholar]
- 45.Sukhorukova EG, Grigoriev IP, Kirik OV, Alekseeva OS, Korzhevskii DE. Intranuclear localization of iron in neurons of mammalian brain. J Evol Biochem Physiol 2013;49:370–2. [Google Scholar]
- 46.Korzhevskii D, Sukhorukova EG, Kirik OV, Grigorev IP. A Cytochemical study of iron-containing intranuclear structures of the human substantia nigra dopaminergic neurons with special emphasis on the Marinesco bodies. Opera Med Physiol 2017;3:99-107. [Google Scholar]
- 47.Reinert A, Morawski M, Seeger J, Arendt T, Reinert T.Iron concentrations in neurons and glial cells with estimates on ferritin concentrations. BMC Neurosci 2019;20:25. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 48.Roschzttardtz H, Grillet L, Isaure M-P, Conéjéro G, Ortega R, Curie C, et al. Plant cell nucleolus as a hot spot for iron. J Biol Chem 2011;286:27863-6. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 49.Surguladze N, Thompson KM, Beard JL, Connor JR, Fried MG. Interactions and reactions of ferritin with DNA. J Biol Chem 2004;279:14694–702. [DOI] [PubMed] [Google Scholar]
- 50.Honda K, Smith MA, Zhu X, Baus D, Merrick WC, Tartakoff AM, et al. Ribosomal RNA in Alzheimer disease is oxidized by bound redox-active iron. J Biol Chem 2005;280:20978-86. [DOI] [PubMed] [Google Scholar]
- 51.Zecca L, Fariello R, Riederer P, Sulzer D, Gatti A, Tampellini D.The absolute concentration of nigral neuromelanin, assayed by a new sensitive method, increases throughout the life and is dramatically decreased in Parkinson's disease. FEBS Lett 2002;510:216-20. [DOI] [PubMed] [Google Scholar]
- 52.Jyothi HJ, Vidyadhara DJ, Mahadevan A, Philip M, Parmar SK, Manohari SG, et al. Aging causes morphological alterations in astrocytes and microglia in human substantia nigra pars compacta. Neurobiol Aging 2015;36:3321-33. [DOI] [PubMed] [Google Scholar]
- 53.Kanaan NM, Kordower JH, Collier TJ. Age-related changes in glial cells of dopamine midbrain subregions in rhesus monkeys. Neurobiol Aging 2010;31:937-52. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 54.Jurga AM, Paleczna M, Kuter KZ. Overview of general and discriminating markers of differential microglia phenotypes. Front Cell Neurosci 2020;14:198. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 55.Hopperton KE, Mohammad D, Trépanier MO, Giuliano V, Bazinet RP. Markers of microglia in post-mortem brain samples from patients with Alzheimer’s disease: a systematic review. Mol Psychiatry 2018; 23:177–98. [DOI] [PMC free article] [PubMed] [Google Scholar]